The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Gagan Harsh Sharma, Promoter and Managing Director of Bliss GVS Pharma, along with Persons Acting in Concert (PACs), acquired 4,707 equity shares through open market purchases on May 22, 2025. Before this acquisition, the promoter group's holding stood at 3,72,66,037 shares (35.37% of total share capital). After the acquisition, the holding marginally increased to 3,72,70,744 shares, still at 35.37% due to the tiny size of the buy relative to the company's total share capital of Rs. 10.53 crore. The disclosure was filed under Regulation 29(1) of SEBI's Takeover Regulations, 2011.
The acquisition is purely symbolic — 4,707 shares is a negligible quantity with no change in promoter percentage (35.37%). This suggests routine promoter buying rather than a strategic stake-building move, so it is unlikely to have any meaningful impact on stock price or shareholder value.